Webinar—Advantages of Terminal Sterilization Over Aseptic Manufacturing

Terminal sterilization is the most effective way to reduce the chances of microbial contamination and provides a higher level of sterility assurance to finished drug products. It is also less complex, less costly, and more easily reproducible than aseptic manufacturing. Discover the full range of benefits by viewing the webinar on-demand. Topics include: • Differences between aseptic processing and terminal sterilization • Common misconceptions about terminal sterilization • Preferences and expectations of regulatory agencies • How to evaluate your product’s compatibility Case study also included! Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. Visit our website to learn more: https://www.altasciences.com/

From Legacy to Leading-Edge: Dairy Plant Modernization Strategies | FPSA Webinar
▶︎

From Legacy to Leading-Edge: Dairy Plant Modernization Strategies | FPSA Webinar

Webinar—Skin in the Game? Get Safety Right: Nonclinical Study Requirements for Dermal Therapies
▶︎

Webinar—Skin in the Game? Get Safety Right: Nonclinical Study Requirements for Dermal Therapies

Webinar - The Development of Nanosuspension Formulations for Poorly Soluble Drugs
▶︎

Webinar - The Development of Nanosuspension Formulations for Poorly Soluble Drugs

The French Do Not Care About Work
▶︎

The French Do Not Care About Work

The $200M Machine that Prints Microchips:  The EUV Photolithography System
▶︎

The $200M Machine that Prints Microchips: The EUV Photolithography System

Nvidia CEO Jensen Huang Interview| Bloomberg Technology Special
▶︎

Nvidia CEO Jensen Huang Interview| Bloomberg Technology Special

Conan O’Brien Delivers the Commencement Address | Harvard Commencement 2026
▶︎

Conan O’Brien Delivers the Commencement Address | Harvard Commencement 2026

Webinar — Bioanalysis by Hybridization ELISA for Antisense Oligonucleotides
▶︎

Webinar — Bioanalysis by Hybridization ELISA for Antisense Oligonucleotides

Webinar: Headspace Gas Ingress Testing for Container Closure Integrity
▶︎

Webinar: Headspace Gas Ingress Testing for Container Closure Integrity

Multi Drug Resistant Organisms and Novel Antimicrobials
▶︎

Multi Drug Resistant Organisms and Novel Antimicrobials

Fire Code Shake-Up: Is Your Lab Ready?
▶︎

Fire Code Shake-Up: Is Your Lab Ready?

Doku: Die geheime Welt des deutschen Adels
▶︎

Doku: Die geheime Welt des deutschen Adels

The Science Behind Dramatically Better Conversations | Charles Duhigg | TED
▶︎

The Science Behind Dramatically Better Conversations | Charles Duhigg | TED

Webinar A Practical Road Map for Compliance to the Container Closure Requirements in the GMP Annex 1
▶︎

Webinar A Practical Road Map for Compliance to the Container Closure Requirements in the GMP Annex 1

Webinar: Non-destructive Moisture Determination for Lyophilization Process
▶︎

Webinar: Non-destructive Moisture Determination for Lyophilization Process

Seth Godin – Leadership vs. Management - What it means to make a difference
▶︎

Seth Godin – Leadership vs. Management - What it means to make a difference

Why the Philippines’ Birth Rate Is Crashing Faster Than Japan | AB Explained
▶︎

Why the Philippines’ Birth Rate Is Crashing Faster Than Japan | AB Explained

How ASML Makes Chips Faster With Its New $400 Million High NA Machine
▶︎

How ASML Makes Chips Faster With Its New $400 Million High NA Machine

MIT Economist on Finance, AI, and Human Behavior
▶︎

MIT Economist on Finance, AI, and Human Behavior

Step Inside Altasciences’ Bioanalytical Facility in Seattle, Washington
▶︎

Step Inside Altasciences’ Bioanalytical Facility in Seattle, Washington